Jefferies raises Charles River Labs stock price target on cost efficiency outlook
Jefferies raises Charles River Labs stock price target on cost efficiency outlook Investing.com
Covered in this story
What has happened since
- Charles River Laboratories is up 6.1% since this was published, 22 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Charles River Laboratories
- Jefferies: $295 → $340 by Sep 2027 · Buy via Investing.com UK
- JPMorgan: $266 → $310 by Aug 2027 · Overweight via Investing.com
- Evercore ISI: $261 → $300 by Aug 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CRL yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Charles River Laboratories →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.